Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Hair transplant surgeons should also focus on their patients' overall health, including regular check-ups and screening for common health issues.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Alopecia should be treated as a medical condition because it may increase the risk of serious diseases and psychological issues.

The journal retracted an article due to inaccurate statistics and asked the authors to revise and resubmit it.

Adding a second method to PROTACs could improve cancer treatment.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Androgenetic alopecia is common, affects self-image, and has no complete cure yet.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

5α-reductase-2 deficiency causes ambiguous genitalia at birth and affects male sexual development, but individuals often develop male characteristics at puberty.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Large prostates link to more hair loss.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Higher DHT in male baldness may protect against prostate cancer.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Finasteride treats hair loss but may affect prostate cancer detection.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.